Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gamida Cell Ltd (NQ: GMDA )

0.9288 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,721
Open 0.9288
Bid (Size) 0.9764 (4)
Ask (Size) 0.9900 (5)
Prev. Close 0.9288
Today's Range 0.9288 - 0.9288
52wk Range 0.5600 - 2.510
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
First Patient Receives Gamida Cell's Omisirge™ (omidubicel-onlv)
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell to Present Corporate Highlights at the H.C. Wainwright 25th Annual Global Investment Conference
From Gamida Cell Ltd.
Via Business Wire

Performance

YTD
-34.13%
-34.13%
1 Month
-25.10%
-25.10%
3 Month
-47.82%
-47.82%
6 Month
+20.62%
+20.62%
1 Year
-52.61%
-52.61%

More News

Read More
Analyst Ratings for Gamida Cell
Via Benzinga
Gamida Cell's Earnings: A Preview
Via Benzinga
Expert Ratings for Gamida Cell
Via Benzinga
Analyst Expectations for Gamida Cell's Future
Via Benzinga
Earnings Outlook For Gamida Cell
Via Benzinga
Despite Early Approval Of Omidubicel, Analyst Says Longer-Term Financial Overhang Remains For Gamida Cell
Via Benzinga
Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell to Report Second Quarter 2023 Financial Results
From Gamida Cell Ltd.
Via Business Wire
Data Published in Transplantation and Cellular Therapy Suggest Antiviral Protection After Transplantation with Gamida Cell’s Omisirge® (omidubicel-onlv)
From Gamida Cell Ltd.
Via Business Wire
Where Gamida Cell Stands With Analysts
Via Benzinga
Gamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference
From Gamida Cell Ltd.
Via Business Wire
Data To Be Presented on Gamida Cell Natural Killer (NK) Cell Therapy Candidate GDA-201 at the International Society for Cell & Gene Therapy 2023 Annual Meeting
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Appoints Terry Coelho as CFO
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Reports First Quarter 2023 Financial Results and Provides Company Update
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Announces the Date of Its First Quarter 2023 Financial Results and Webcast
From Gamida Cell Ltd.
Via Business Wire
Why MIND Technology Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Virax Biolabs (VRAX) Stock Soars on PCR Test DIstribution Agreement
Via InvestorPlace
LUNR Stock Alert: The $719 Million Reason Intuitive Machines Is Rising Today
Via InvestorPlace
Why Is Gamida Cell (GMDA) Stock Down 19% Today?
Via InvestorPlace
Gamida Cell Announces Pricing of $23 Million Public Offering of Securities
From Gamida Cell Ltd.
Via Business Wire
Why Sonnet BioTherapeutics Shares Are Trading Lower By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.